PipelinePharma Logo

Generics 9

Innovative

Biosimilars

Medical devices

Nutraceuticals

Filters

Dabigatran etexilate mesylate manufacturers

9 products found

Filters

Filters

Filters , active

Country of origin : India

Clear all

9 products found

dabigatran etexilate mesylate

Capsules 75 mg, 110 mg, 150 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #17643
This company specializes in the development and manufacturing of Active Pharmaceutical Ingredients (APIs) and intermediates, focusing on cost-effective solutions with a strong emphasis on quality. They offer contract development and manufacturing services (CDMO) for both New Chemical Entities (NCEs) and APIs, leveraging their globally compliant GMP facilities and expertise in modified release technologies. The company boasts state-of-the-art production lines capable of handling high-potent materials across various scales, catering to a wide range of pharmaceutical products including prescription medications and potentially over-the-counter drugs. While specific therapy areas aren't mentioned, they hold patents for their innovations and are actively involved in research and development. Their operations span multiple regions, including North America and the EU.

Manufacturer usually replies in 2 days

dabigatran etexilate mesylate

Capsules 75 mg, 110 mg, 150 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Unavailable markets
Antigua And/Or Barbuda , Argentina , Bahamas , Barbados , Belize , Bolivia , Brazil , Chile , Colombia , Costa Rica , Cuba , Dominica , Dominican Republic , Ecuador , El Salvador , Grenada , Guatemala , Guyana , Haiti , Honduras , Jamaica , Mexico , Nicaragua , Panama , Paraguay , Peru , Suriname , Uruguay , Venezuela
Available for
Licensing with supply
Comments
Ref. product: Pradaxa® Boehringer Ingelheim
Manufacturer #261
A pharmaceutical manufacturer based in the EU that has been selling its products in Europe for 20+ years. Main therapeutic areas include diabetes, CNL, dermatology, and oncology. Main dosage forms include solid and liquid oral, sterile dosage forms, and ointments. The company possesses 10+ manufacturing facilities that are cGMP-compliant.

Manufacturer usually replies in 20 days

dabigatran etexilate mesylate

Capsules 75 mg, 110 mg, 150 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
India
GMP approvals
EU GMP
Unavailable markets
United Kingdom
Manufacturer #21496

This CTD dossier owner and manufacturer is a fully integrated pharmaceutical corporation with a global reach. The company specializes in CMO and CDMO pharmaceutical preparations in a variety of dosage forms for a variety of therapeutic categories. GSK, Pfizer, Sanofi, Novartis, Mylan, Apotex, Adcock Ingram, and other MNCs manufacture formulations in various dosage forms for customers in 55 countries in important markets such as Europe, Australia & New Zealand, Canada, Japan, Far East Asia, GCC, Africa, LATAM, and CIS.

Manufacturer usually replies in 23 days

Want to see all 9 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Dabigatran etexilate mesylate:

Dabigatran etexilate mesylate is commonly referred to simply as dabigatran, where it is sold under its popular brand name of Pradaxa, among others. It is an anticoagulant medication used to treat blood clot formation and to prevent strokes in people with atrial fibrillation. It is particularly used in this function post hip or knee replacement surgery in those with a history of prior clots. As it does not require monitoring by blood tests, it has made it a choice alternative to warfarin.
Dabigatran was originally developed by a manufacturing company involved in producing pharmaceutical products, which subsequently submitted and gained it medical approval in the United States by the FDA in 2010. Currently, it is on the World Health Organization's List of Essential Medicines, indicating that it is both efficient and cost-effective, making it recommended for use in health systems across the globe. This has made it attractive for dabigatran etexilate mesylate manufacturers and dabigatran etexilate mesylate suppliers to list for sale to distributors. Where it can be found available for wholesale order across the global marketplace, at a variety of cost and price points.

Method of action of dabigatran etexilate mesylate:

Dabigatran belongs to a group of drugs that function through the inhibition of thrombin, disrupting the coagulation cascade and subsequent clotting. This is enabled through reversibly binding to the active site on the thrombin molecule, preventing thrombin-mediated activation of coagulation factors, regardless if thrombin is fibrin-bound. This makes it also capable of reducing thrombin-mediated inhibition of fibrinolysis and thus may also serve to enhance fibrinolysis.

Form and dosage of dabigatran etexilate mesylate:

The final form and packaging of dabigatran etexilate mesylate is dependent on both the manufacturers and suppliers, as well as the specific distributors and order. However, typically it is available for wholesale order in forms including capsules, tablets, and film-coated tablets. Dabigatran etexilate mesylate is a controlled substance, as such, the prescribing medical official will determine a patient-specific regime. This will be based on indications such as the underlying ailment, age, and other risk factors.

Dabigatran etexilate mesylate on Pipelinepharma:

Currently, at the time of writing, we have found 3 verified dabigatran etexilate mesylate manufacturers and dabigatran etexilate mesylate suppliers from our online global list of B2B sellers. These manufacturers, suppliers, and distributors are located in countries including India and the European Union. All listings on our online B2B database have been verified by the Pipelinepharma team according to strict quality control. This improves buyer ease and facilitates a quick and painless sourcing experience.

Price of dabigatran etexilate mesylate and how to buy:

A cursory search online reveals an approximate wholesale cost of dabigatran etexilate mesylate to be USD 46.23 for 100 x 110 mg capsules from India. However, this indicated price is vague and is not intended as a decisive guideline. The price of all pharmaceutical products is highly dependent on numerous variables such as market, organisation, manufacturers, quantity, and many others.
Although the cost of dabigatran etexilate mesylate is not normally listed on our online company B2B marketplace. The manufacturers or suppliers may choose to display a desired cost in their listing. If so, this will be indicated alongside an ‘Accept’ and ‘Negotiate’ button, with a ‘Get offer’ button being displayed in its absence. This facilitates the negotiation process by providing a baseline for expectations, expediting the sourcing experience for both parties.

Popular Searches

Amoxicillin manufacturers Atorvastatin manufacturers Benzocaine manufacturers Calcium carbonate manufacturers Cloperastine fendizoate manufacturers Gabapentin manufacturers Hyaluronic acid manufacturers Ibuprofen manufacturers Ivermectin manufacturers Levothyroxine manufacturers Lisinopril manufacturers Losartan manufacturers Magnesium manufacturers Melatonin manufacturers Metformin manufacturers Methotrexate manufacturers Metoprolol manufacturers Omeprazole manufacturers Paracetamol manufacturers Prednisone manufacturers Pregabalin manufacturers Semaglutide manufacturers Testosterone enanthate manufacturers Vitamin B12 manufacturers

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.